Personalized Stem Cells Enrolls in Clinical Trial for Treatment of OA with Stem Cells

Personalized Stem Cells (PSC) enrolled the first of up to 125 patients in its FDA-approved clinical trial for stem cell treatment of knee osteoarthritis. Trial sites are located throughout the U.S., with more to come in 4Q19 and early 2020. Future trials are planned for other orthopedic applications, including hips and shoulders.

PSC is...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us